Eltrombopag
| CAS No. | 496775-61-2 |
|---|---|
| MDL No. | MFCD20926253 |
| MF | C25H22N4O4 |
| MW | 442.50 |
| InChI Key | XDXWLKQMMKQXPV-QYQHSDTDSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Eltrombopag is a substituted hydrazine, with one nitrogen substituted by a 3'-carboxy-2-hydroxy[1,1'-biphenyl]-3-yl group and the other by a 1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene group. It is a small molecule agonist of the c-mpl (TpoR) receptor, the physiological target of thrombopoietin, and is used to treat thrombocytopenia. It functions as a thrombopoietin receptor agonist and xenobiotic, and belongs to the classes of hydrazines, pyrazoles, and benzoic acids.
| CAS No. | 496775-61-2 |
|---|---|
| Product Name | Eltrombopag |
Biological Targets
MPL
Associated Conditions
myelodysplastic syndrome·liver disease·Aplastic anemia·autoimmune thrombocytopenic purpura·leukemia·
* The information provided here is compiled from public sources and is for reference only.
